Livermore Partners Managing Director David Neuhauser weighs in on “Bloomberg Markets.”

Contact Livermore Partners

Valeant Pharmaceuticals International Inc. shares plunged in their worst day ever, falling as much as 49 percent after the company cut its 2016 forecast, reported a weak fourth quarter and said it risked breaching some of its debt agreements if it can’t file its annual report in time.

This video was originally featured on Bloomberg on 03/15/2016